US Food and Drug Administration (USFDA) has issued a ‘DMF information request’ to SMS Pharmaceuticals to provide the information to demonstrate its Ranitidine API manufacturing process does not contain NDMA impurity.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities.